The Parallel Between Covid-19 and Polio: A Historical Perspective
Written on
When I was younger, my family visited Philadelphia during the initial outbreak of Legionnaire’s Disease in July 1976, coinciding with the nation's bicentennial. Instead of bustling crowds, the city was hauntingly deserted, with anyone venturing outside keeping their heads down and moving quickly.
During that time, illness was spreading, and fatalities were occurring without a clear cause, leading many to stay indoors for safety. The atmosphere resembled something from a dystopian film, and my parents shared a knowing glance.
“This is how it felt during the Polio outbreaks,” my mother said, lowering her voice at the mention of the disease—a reflex borne from fear of invoking its memory, much like how people discuss cancer.
Having been born in the 1920s, my parents vividly remembered the pre-vaccine era of Polio, their accounts so striking that they remain etched in my mind even decades later.
Similarities Between the Diseases
Both Polio and Covid-19 share notable similarities. Each has multiple strains; Polio consists of three distinct types, while Covid-19 has presented at least five variants to date.
The Mayo Clinic notes that most individuals infected with Polio may be unaware of their condition. In a similar vein, asymptomatic cases of Covid-19 can lead to individuals unknowingly spreading the virus.
For those who do exhibit symptoms, they often begin mildly, resembling flu-like indicators. After about a week, the situation either improves or deteriorates significantly. In the case of Covid-19, severe outcomes may include pneumonia or the need for ventilators, while Polio can result in muscle weakness or paralysis.
Both illnesses have low mortality rates, yet serious cases lead to enduring health complications. Polio survivors often face lifelong challenges, including muscle weakness or paralysis and reliance on iron lungs for breathing. Moreover, Post-Polio Syndrome may emerge 15 to 40 years after recovery, bringing new symptoms.
As for Covid-19, the concept of “long Covid” is still under investigation, with symptoms that can persist for months, such as fatigue, strokes, temporary paralysis, and lung damage that may necessitate oxygen support.
Vaccine Development Parallels
You may recall from school that Jonas Salk introduced the Polio vaccine in the 1950s, leading to its near eradication in the US and Europe (though it persists in parts of Asia and Africa). However, this is a simplification of a complex history.
Salk developed the first Polio vaccine in 1954, followed by extensive trials in 1955, prompting a rapid production rollout in the US despite insufficient safety measures. The vaccine utilized killed Polio virus cells, but initial production errors led to over 100,000 individuals receiving a live virus, resulting in illness and fatalities. This prompted a recall and a comprehensive investigation, yet the vaccine has since been improved and remains in use.
An oral vaccine, created by Albert Sabin and Hilary Koprowski in 1957, avoided the pitfalls of Salk's injection. As the US continued to promote the Salk vaccine, the oral version was successfully trialed in Russia and became the preferred option in much of the world by 1961 due to its ease of administration.
In 1955, there were around 29,000 documented Polio cases in the US. Just two years post-implementation of the Salk vaccine, cases plummeted to fewer than 6,000, showcasing the vaccine's effectiveness.
In 2020, the first Covid-19 vaccines were developed, with large-scale production commencing in 2021. These vaccines were primarily effective against the original Alpha variant but showed diminished efficacy against subsequent strains. Despite this, they still seem to prevent severe cases.
Public skepticism surrounding the Covid-19 vaccines mirrors the reactions to the initial Polio vaccine recall, with many expressing concerns about the speed of development and unknown long-term effects.
Similar to the Polio narrative, research is ongoing for new oral Covid-19 vaccines, currently being tested in Israel. The popularity of an oral vaccine may rise as it addresses fears associated with injections.
Key Differences Between the Diseases
A significant distinction exists between the two diseases: Polio is a stable virus, still active in regions like Pakistan and Afghanistan. While global vaccination efforts have largely prevented epidemics, isolated cases still pose risks, with the last US case recorded in 2005 involving an unvaccinated traveler.
Conversely, Covid-19 mutates rapidly, allowing vaccinated individuals to still become infected by new variants. The Delta variant has garnered attention for its heightened severity, while the Lambda variant, already in the US, has been particularly disruptive in South America, raising concerns about its ability to evade vaccine protections.
Lessons from History
Given the parallels between the two diseases, we may glean valuable insights from the Polio fight to combat Covid-19.
Both diseases lack cures once contracted; hence, prevention through vaccination, sanitation, and protective measures (like masks and social distancing) is crucial. Treatment remains primarily focused on alleviating symptoms, such as providing respiratory support for severely affected patients.
In 1949, President Harry Truman declared a nationwide war against Polio, emphasizing the necessity for a unified effort across the country. Although there were no federal mandates, local and state governments heeded national scientific guidance, adapting recommendations to their specific communities.
In contrast, the response to Covid-19 has varied significantly by state, with mixed levels of adherence to scientific recommendations. The rapid spread of the pandemic has led to often contradictory best practices as new information emerges.
Perhaps a more effective Covid response would involve local jurisdictions following consistent national guidelines, allowing tailored approaches that consider local conditions.
Potential Treatments from History
Polio survivors explored numerous treatments to enhance their recovery.
Rehabilitation efforts primarily aimed at preserving muscle mass and restoring strength post-Polio. Organizations like the March of Dimes funded physical therapy for around 80% of Polio victims who could not afford treatment. They even established hospitals specifically for Polio care. It’s conceivable that a similar charity could emerge for Covid-19 patients, funded by a wealthy individual who contracts the virus.
Nutritional strategies focused on consuming fresh fruits, vegetables, and proteins while minimizing starches and sugars, known to reduce inflammation. The concept of a "long Covid diet" could soon gain traction, promoting similar dietary principles.
Conclusion
The parallels between Covid-19 and Polio are striking. Both diseases often present with mild or no symptoms in most cases, while severe instances can lead to lasting health issues.
The histories of vaccine development for both illnesses also reveal similarities: the initial Polio vaccine was an injection, followed by an oral version, just as the first Covid-19 vaccines were injections, with oral alternatives currently being researched.
Ultimately, history may provide guidance in addressing Covid-19. Effective vaccination, sanitation, and protective measures are vital, as is a singular, reliable source of health information that adapts to local needs.
A national charitable organization, supported by public and political backing, could help alleviate the financial burden on those who fall ill and swiftly establish specialized healthcare facilities, which could later be repurposed as necessary.
An anti-inflammatory diet might also aid those with long-Covid in managing their symptoms.
Get my free guide to increasing your confidence here!